Adi Zuloff-Shani
Chief Executive Officer bei CLEARMIND MEDICINE INC.
Vermögen: 1 929 $ am 31.03.2024
Profil
Adi Zuloff-Shani is currently the Chief Executive Officer at Clearmind Medicine, Inc., Chairman at Orsus Therapeutics Plc, Director at MitoCareX Bio Ltd., and Chief Technology Officer at SciSparc Ltd.
Previously, Adi held the position of Vice President-Development at Macrocure Ltd.
Adi's education includes undergraduate and doctorate degrees from Bar-Ilan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLEARMIND MEDICINE INC.
0,05% | 31.10.2023 | 1 667 ( 0,05% ) | 1 917 $ | 31.03.2024 |
SCISPARC LTD.
0,00% | 24.04.2023 | 7 ( 0,00% ) | 12 $ | 31.03.2024 |
Aktive Positionen von Adi Zuloff-Shani
| Unternehmen | Position | Beginn |
|---|---|---|
| SCISPARC LTD. | Chief Tech/Sci/R&D Officer | 08.02.2016 |
| CLEARMIND MEDICINE INC. | Chief Executive Officer | 14.07.2021 |
| Orsus Therapeutics Plc | Chairman | 01.11.2021 |
Ehemalige bekannte Positionen von Adi Zuloff-Shani
| Unternehmen | Position | Ende |
|---|---|---|
| MACROCURE LTD | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Adi Zuloff-Shani
| Bar-Ilan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SCISPARC LTD. | Health Technology |
| CLEARMIND MEDICINE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
| Orsus Therapeutics Plc |
